Literature DB >> 23408627

Immunogenicity of a vaccine regimen composed of simian immunodeficiency virus DNA, rMVA, and viral particles administered to female rhesus macaques via four different mucosal routes.

Mariana Manrique1, Pamela A Kozlowski, Antonio Cobo-Molinos, Shainn-Wei Wang, Robert L Wilson, David C Montefiori, Angela Carville, Anna Aldovini.   

Abstract

A comparative evaluation of the immunity stimulated with a vaccine regimen that includes simian immunodeficiency virus (SIV), interleukin 2 (IL-2), and IL-15 DNAs, recombinant modified vaccinia virus Ankara (rMVA), and inactivated SIVmac239 particles administered into the oral and nasal cavities, small intestine, and vagina was carried out in female rhesus macaques to determine the best route to induce diverse anti-SIV immunity that may be critical to protection from SIV infection and disease. All four immunizations generated mucosal SIV-specific IgA. Oral immunization was as effective as vaginal immunization in inducing SIV-specific IgA in vaginal secretions and generated greater IgA responses in rectal secretions and saliva samples compared to the other immunization routes. All four immunizations stimulated systemic T-cell responses against Gag and Env, albeit to a different extent, with oral immunization providing greater magnitude and nasal immunization providing wider functional heterogeneity. SIV-specific T cells producing gamma interferon (IFN-γ) dominated these responses. Limited levels of SIV-specific IgG antibodies were detected in plasma samples, and no SIV-specific IgG antibodies were detected in secretions. Vaccination also induced CD4(+) and CD8(+) T-cell responses in the rectal and vaginal mucosa with greater functional heterogeneity than in blood samples. Rectal T-cell responses were significantly greater in the orally vaccinated animals than in the other animals. The most balanced, diverse, and higher-magnitude vaginal T-cell responses were observed after intestinal vaccination. Significantly higher CD8(+) granzyme B-positive T-cell responses were observed systemically after intestinal vaccination and in rectal cells after oral immunization. The majority of SIV-specific T cells that produced granzyme B did not produce cytokines. Of the immunization routes tested, oral vaccination provided the most diverse and significant response to the vaccine.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23408627      PMCID: PMC3624383          DOI: 10.1128/JVI.03531-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit.

Authors:  A Rudin; G C Riise; J Holmgren
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

2.  Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity.

Authors:  SangKon Oh; Jay A Berzofsky; Donald S Burke; Thomas A Waldmann; Liyanage P Perera
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

3.  Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers.

Authors:  B D Kirkpatrick; Robin McKenzie; J Patrick O'Neill; Catherine J Larsson; A Louis Bourgeois; Janet Shimko; Matthew Bentley; Jill Makin; Steve Chatfield; Zoë Hindle; Christine Fidler; Brad E Robinson; Cassandra H Ventrone; Nivedita Bansal; Colleen M Carpenter; Deborah Kutzko; Sandra Hamlet; Casey LaPointe; David N Taylor
Journal:  Vaccine       Date:  2005-08-18       Impact factor: 3.641

4.  SPICE: exploration and analysis of post-cytometric complex multivariate datasets.

Authors:  Mario Roederer; Joshua L Nozzi; Martha C Nason
Journal:  Cytometry A       Date:  2011-01-07       Impact factor: 4.355

5.  Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world.

Authors:  A B Sabin
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

6.  A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing.

Authors:  L A Knapp; E Lehmann; M S Piekarczyk; J A Urvater; D I Watkins
Journal:  Tissue Antigens       Date:  1997-12

Review 7.  Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.

Authors:  Robert Belshe; Min-Shi Lee; Robert E Walker; Jeffrey Stoddard; Paul M Mendelman
Journal:  Expert Rev Vaccines       Date:  2004-12       Impact factor: 5.217

Review 8.  Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines.

Authors:  Igor M Belyakov; Jay A Berzofsky
Journal:  Immunity       Date:  2004-03       Impact factor: 31.745

9.  Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin.

Authors:  Antonella Caputo; Egidio Brocca-Cofano; Arianna Castaldello; Rebecca Voltan; Riccardo Gavioli; Indresh K Srivastava; Susan W Barnett; Aurelio Cafaro; Barbara Ensoli
Journal:  Vaccine       Date:  2008-01-15       Impact factor: 3.641

10.  Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants.

Authors:  G Douce; C Turcotte; I Cropley; M Roberts; M Pizza; M Domenghini; R Rappuoli; G Dougan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

View more
  16 in total

1.  Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.

Authors:  Sudhir Pai Kasturi; Pamela A Kozlowski; Helder I Nakaya; Matheus C Burger; Pedro Russo; Mathew Pham; Yevgeniy Kovalenkov; Eduardo L V Silveira; Colin Havenar-Daughton; Samantha L Burton; Katie M Kilgore; Mathew J Johnson; Rafiq Nabi; Traci Legere; Zarpheen Jinnah Sher; Xuemin Chen; Rama R Amara; Eric Hunter; Steven E Bosinger; Paul Spearman; Shane Crotty; Francois Villinger; Cynthia A Derdeyn; Jens Wrammert; Bali Pulendran
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

2.  Resistance to infection, early and persistent suppression of simian immunodeficiency virus SIVmac251 viremia, and significant reduction of tissue viral burden after mucosal vaccination in female rhesus macaques.

Authors:  Mariana Manrique; Pamela A Kozlowski; Antonio Cobo-Molinos; Shainn-Wei Wang; Robert L Wilson; Maria del Pilar Martinez-Viedma; David C Montefiori; Angela Carville; Anna Aldovini
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

3.  Vaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus Macaques.

Authors:  Kara Jensen; Rafiq Nabi; Koen K A Van Rompay; Spencer Robichaux; Jeffrey D Lifson; Michael Piatak; William R Jacobs; Glenn Fennelly; Don Canfield; Katie R Mollan; Michael G Hudgens; Michelle H Larsen; Angela M Amedee; Pamela A Kozlowski; Kristina De Paris
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

4.  Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaques.

Authors:  Antonio Valentin; Katherine McKinnon; Jinyao Li; Margherita Rosati; Viraj Kulkarni; Guy R Pilkington; Jenifer Bear; Candido Alicea; Diego A Vargas-Inchaustegui; L Jean Patterson; Poonam Pegu; Namal P M Liyanage; Shari N Gordon; Monica Vaccari; Yichuan Wang; Alison E Hogg; Blake Frey; Yongjun Sui; Steven G Reed; Niranjan Y Sardesai; Jay A Berzofsky; Genoveffa Franchini; Marjorie Robert-Guroff; Barbara K Felber; George N Pavlakis
Journal:  Clin Immunol       Date:  2014-09-16       Impact factor: 3.969

5.  Rhesus macaque rectal and duodenal tissues exhibit B-cell sub-populations distinct from peripheral blood that continuously secrete antigen-specific IgA in short-term explant cultures.

Authors:  Michael A Thomas; Thorsten Demberg; Diego A Vargas-Inchaustegui; Peng Xiao; Iskra Tuero; David Venzon; Deborah Weiss; James Treece; Marjorie Robert-Guroff
Journal:  Vaccine       Date:  2013-12-25       Impact factor: 3.641

6.  A simultaneous oral and intramuscular prime/sublingual boost with a DNA/Modified Vaccinia Ankara viral vector-based vaccine induces simian immunodeficiency virus-specific systemic and mucosal immune responses in juvenile rhesus macaques.

Authors:  Alan D Curtis; Kara Jensen; Koen K A Van Rompay; Rama R Amara; Pamela A Kozlowski; Kristina De Paris
Journal:  J Med Primatol       Date:  2018-09-11       Impact factor: 0.667

7.  Comparative Evaluation of Prophylactic SIV Vaccination Modalities Administered to the Oral Cavity.

Authors:  Omkar Chaudhary; Lingyun Wang; Deepanwita Bose; Vivek Narayan; Ming Te Yeh; Angela Carville; John D Clements; Raul Andino; Pamela A Kozlowski; Anna Aldovini
Journal:  AIDS Res Hum Retroviruses       Date:  2020-10-27       Impact factor: 2.205

Review 8.  Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infection.

Authors:  Jordan Poles; Yelina Alvarez; Catarina E Hioe
Journal:  AIDS Res Hum Retroviruses       Date:  2014-11       Impact factor: 2.205

9.  Oral Vaccination Approaches for Anti-SHIV Immunity.

Authors:  Erandi Velarde de la Cruz; Lingyun Wang; Deepanwita Bose; Sailaja Gangadhara; Robert L Wilson; Rama R Amara; Pamela A Kozlowski; Anna Aldovini
Journal:  Front Immunol       Date:  2021-06-21       Impact factor: 7.561

10.  Invaplex functions as an intranasal adjuvant for subunit and DNA vaccines co-delivered in the nasal cavity of nonhuman primates.

Authors:  Jeremy V Camp; Robert L Wilson; Morgan Singletary; James L Blanchard; Anna Aldovini; Robert W Kaminski; Edwin V Oaks; Pamela A Kozlowski
Journal:  Vaccine X       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.